These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17878471)

  • 1. Placebo versus best-available-therapy control group in clinical trials for pharmacologic therapies: which is better?
    Castro M
    Proc Am Thorac Soc; 2007 Oct; 4(7):570-3. PubMed ID: 17878471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What makes placebo-controlled trials unethical?
    Miller FG; Brody H
    Am J Bioeth; 2002; 2(2):3-9. PubMed ID: 12189059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.
    Temple R; Ellenberg SS
    Ann Intern Med; 2000 Sep; 133(6):455-63. PubMed ID: 10975964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pros and cons of noninferiority trials.
    Pocock SJ
    Fundam Clin Pharmacol; 2003 Aug; 17(4):483-90. PubMed ID: 12914552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.
    Ellenberg SS; Temple R
    Ann Intern Med; 2000 Sep; 133(6):464-70. PubMed ID: 10975965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ethics of placebo-controlled trials: the case of asthma.
    Onder RF
    J Allergy Clin Immunol; 2005 Jun; 115(6):1228-34. PubMed ID: 15940139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sham procedure versus usual care as the control in clinical trials of devices: which is better?
    Sutherland ER
    Proc Am Thorac Soc; 2007 Oct; 4(7):574-6. PubMed ID: 17878472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled trials in psychiatric research: an ethical perspective.
    Miller FG
    Biol Psychiatry; 2000 Apr; 47(8):707-16. PubMed ID: 10773177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trials using antidepressants and antipsychotics. The pros and cons of placebo control].
    Broich K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):541-7. PubMed ID: 15887064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials: active control vs placebo--what is ethical?
    Spławiński J; Kuźniar J
    Sci Eng Ethics; 2004 Jan; 10(1):73-9. PubMed ID: 14986774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical issues in the difference between placebo-controlled and active-controlled trials.
    Petrini C
    Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197
    [No Abstract]   [Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials.
    Howick J
    Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conflating scientific with clinical considerations.
    van der Graaf R; van Delden JJ
    Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198
    [No Abstract]   [Full Text] [Related]  

  • 16. Placebo and the Helsinki Declaration--what to do?
    Vrhovac B
    Sci Eng Ethics; 2004 Jan; 10(1):81-93. PubMed ID: 14986775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When are placebo-controlled trials no longer appropriate?
    Brody BA
    Control Clin Trials; 1997 Dec; 18(6):602-12; discussion 661-6. PubMed ID: 9408722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era.
    McFarland HF; Reingold SC
    Mult Scler; 2005 Dec; 11(6):669-76. PubMed ID: 16320726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control interventions in randomised trials among people with mental health disorders.
    Faltinsen E; Todorovac A; Staxen Bruun L; Hróbjartsson A; Gluud C; Kongerslev MT; Simonsen E; Storebø OJ
    Cochrane Database Syst Rev; 2022 Apr; 4(4):MR000050. PubMed ID: 35377466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we reconsider the routine use of placebo controls in clinical research?
    Avins AL; Cherkin DC; Sherman KJ; Goldberg H; Pressman A
    Trials; 2012 Apr; 13():44. PubMed ID: 22540350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.